<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-07T11:38:29+00:00">
  <iati-activity last-updated-datetime="2026-11-07T09:53:07+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-DJI-Z-UNDP-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Support the national Malaria, TB, and HIV programs in scaling up interventions, treatment and care services nationwide, among the most affected populations - Djibouti (01-Jan-2021-31-Dec-2023)</narrative>
    </title>
    <description type="1">
      <narrative>Djibouti, Multicomponent, United Nations Development Programme</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Réduire de moitié les nouvelles infections par le VIH d'ici à 2022 / Reduce new HIV infections by half by 2022; Allonger l'espérance de vie et la qualité de vie des personnes infectés  et affectés par le VIH et les agents de co-morbidité / Increase the life expectancy and quality of life of people infected and affected by HIV and co-morbidities; Mettre fin à la tuberculose » à l’horizon 2030 / End  Tuberculosis  by 2030; Contribuer à l’amélioration de l’état de santé de la population de la République de Djibouti par la réduction du fardeau humain et socio-économique dus au paludisme / To contribute to the improvement of the population of the Republic of Djibouti state of health by reducing the human and socio-economic burden due to malaria. Objectives: Au moins 90% des PVVIH connaissent leur statut sérologique d’ici à 2022 / At least 90% of PLHIV know their HIV status by 2022; Le taux de survie à 12, 24 et 36 mois est de respectivement de 95%, 93% et 90%, d’ici 2022 / Retention rates at 12, 24 and 36 months are 95%, 93% and 90%, respectively, by 2022; Identifier au moins 9.000 cas de tuberculose sensible et au moins 300 TB-MR d’ici à fin 2024 / Identify at least 9,000 cases of drug-susceptible TB and at least 300 MDR-TB by the end of 2024; Guérir au moins 90% des tuberculoses prouvées bactériologiquement et plus de 75% des tuberculoses résistantes à la rifampicine d’ici 2024 / Cure at least 90% of bacteriologically proven tuberculosis and more than 75% of rifampicin-resistant tuberculosis by 2024; Prévention de la tuberculose / Prevent tuberculosis; Renforcer les capacités managériales et d’intervention de l’unité centrale du programme / Strengthen the managerial and intervention capacities of the programme's central unit; Réduire la mortalité due au paludisme dans les formations sanitaires d’ici fin 2024 / Reduce malaria mortality in health facilities by the end of 2024; Réduire la morbidité liée au paludisme de 50% d’ici 2024, par rapport aux données de 2019 en vue d’atteindre zéro cas autochtone d’ici fin 2030 / Reduce malaria morbidity by 50% by 2024, compared to 2019 data, with the aim of reaching zero indigenous cases by the end of 2030.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="40" role="2" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <participating-org type="40" role="4" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <other-identifier ref="DJI-Z-UNDPP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="3" />
    <activity-date type="1" iso-date="2021-01-01" />
    <activity-date type="2" iso-date="2021-01-01" />
    <activity-date type="3" iso-date="2023-12-31" />
    <activity-date type="4" iso-date="2023-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="DJ" percentage="100">
      <narrative>Djibouti</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12110" percentage="50.29">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="12262" percentage="20.64">
      <narrative>Malaria</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="17.69">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="11.38">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="f83bbdd0-a94f-473b-9cc3-ae8a59141348" percentage="5.93">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing</narrative>
        </description>
      </budget-item>
      <budget-item code="8cc23209-2129-4c18-b058-a4c3a63b6ae4" percentage="0.01">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Prong 3: Preventing vertical HIV transmission</narrative>
        </description>
      </budget-item>
      <budget-item code="c4df5dc6-61af-4f19-a9db-1c6cd15116c2" percentage="0.05">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Prong 4: Treatment, care and support to mothers living with HIV, their children and families</narrative>
        </description>
      </budget-item>
      <budget-item code="88657fe2-2942-4159-860a-af9e84e64238" percentage="1.74">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Behavior change interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="e5a28ba0-ab59-4fc0-aba6-e677caad3c6c" percentage="0.07">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Gender-based violence prevention and post violence care</narrative>
        </description>
      </budget-item>
      <budget-item code="7eb04704-e70b-48cf-94f5-ca1a78006662" percentage="0.08">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Prevention and management of co-infections and co-morbidities (Prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="b0eb178f-7923-4f1d-a0dc-04aed075b79a" percentage="9.33">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Differentiated ART service delivery and HIV care</narrative>
        </description>
      </budget-item>
      <budget-item code="582a5bc6-226b-4ea9-9391-54880da66119" percentage="0.25">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Prevention and management of co-infections and co-morbidities (Treatment, care and support)</narrative>
        </description>
      </budget-item>
      <budget-item code="62adfb99-3345-4b03-ad9f-89b544624a5b" percentage="0.23">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load</narrative>
        </description>
      </budget-item>
      <budget-item code="c57a87ac-a92d-42c4-a1c4-71e7b1488c68" percentage="6.19">
        <description>
          <narrative>Malaria -&gt; Case management -&gt; Facility-based treatment</narrative>
        </description>
      </budget-item>
      <budget-item code="291c8ab4-2749-4be4-87a2-798133758f8d" percentage="0.08">
        <description>
          <narrative>Malaria -&gt; Case management -&gt; Other case management intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="1d2e1f68-1415-409d-aa0b-05765dd07eea" percentage="0.77">
        <description>
          <narrative>Malaria -&gt; Case management -&gt; Private sector case management</narrative>
        </description>
      </budget-item>
      <budget-item code="ca8c73dd-c711-4b02-8bee-aec7ba38d204" percentage="0.09">
        <description>
          <narrative>Malaria -&gt; Case management -&gt; Therapeutic efficacy surveillance</narrative>
        </description>
      </budget-item>
      <budget-item code="75fb98a9-9f2d-4148-af97-5b067ab6d941" percentage="0.07">
        <description>
          <narrative>Malaria -&gt; Vector control -&gt; Entomological monitoring</narrative>
        </description>
      </budget-item>
      <budget-item code="da971a88-3dd5-4770-b907-92f59b276ce7" percentage="0.12">
        <description>
          <narrative>Malaria -&gt; Vector control -&gt; IEC/BCC (Vector control)</narrative>
        </description>
      </budget-item>
      <budget-item code="8aa29a94-e90d-4b65-b94c-c02be992c401" percentage="5.84">
        <description>
          <narrative>Malaria -&gt; Vector control -&gt; Indoor residual spraying (IRS)</narrative>
        </description>
      </budget-item>
      <budget-item code="e41ccb7b-b789-49a2-92b4-d8930689e272" percentage="0.13">
        <description>
          <narrative>Malaria -&gt; Vector control -&gt; Long-lasting insecticidal nets (LLIN) - Continuous distribution - Community-based</narrative>
        </description>
      </budget-item>
      <budget-item code="1c7a6c73-2778-4b7c-ac64-5fc1d74dd939" percentage="7">
        <description>
          <narrative>Malaria -&gt; Vector control -&gt; Long-lasting insecticidal nets (LLIN) - Mass campaign - Universal</narrative>
        </description>
      </budget-item>
      <budget-item code="86d57ea1-200e-49e5-844a-7a89b5064fc0" percentage="0.36">
        <description>
          <narrative>Malaria -&gt; Vector control -&gt; Other vector control measures</narrative>
        </description>
      </budget-item>
      <budget-item code="6a7cb452-4c5d-49b6-aa43-8437d24fa1c5" percentage="28.48">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="31a8e187-9648-42f5-a520-92e7e53d4ac6" percentage="17.4">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="a459608e-6d6a-4392-8e91-a6ce763883ca" percentage="0.39">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-based monitoring</narrative>
        </description>
      </budget-item>
      <budget-item code="792f3049-9f2b-41ae-a2df-af58779797ea" percentage="0.07">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led research and advocacy</narrative>
        </description>
      </budget-item>
      <budget-item code="25710664-d25f-448a-9b94-5e4b210a97c6" percentage="0.11">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Institutional capacity building, planning and leadership development</narrative>
        </description>
      </budget-item>
      <budget-item code="d110361a-331b-4f72-bd32-016450445cc3" percentage="0.41">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="7d2483ee-e340-40e2-8f81-88b761c385aa" percentage="0.45">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="b235c58e-3a80-49b8-aeb9-ddaad2b16768" percentage="0.21">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="cc2a3288-298b-4e87-9cd4-3b8c1601d54c" percentage="0.03">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Policy, strategy, governance</narrative>
        </description>
      </budget-item>
      <budget-item code="5c6d2150-43bf-412f-a249-05dbaa402867" percentage="0.16">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Procurement capacity</narrative>
        </description>
      </budget-item>
      <budget-item code="45f58950-e70b-425c-a83d-28115a57a936" percentage="0.02">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Regulatory/quality assurance support</narrative>
        </description>
      </budget-item>
      <budget-item code="73afa0ce-d818-4bb2-adeb-c13f28c03a1f" percentage="0.67">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Storage and distribution capacity</narrative>
        </description>
      </budget-item>
      <budget-item code="86ab2998-11d1-439b-a3b8-c56ee091314c" percentage="0.04">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector governance and planning -&gt; Policy and planning for national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="1b7258e5-95a1-4ad0-aa27-849d84eb27b3" percentage="0.07">
        <description>
          <narrative>RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; In-service training (excluding community health workers)</narrative>
        </description>
      </budget-item>
      <budget-item code="fcefda7f-7f79-40d5-92ba-393c34a2616c" percentage="0.03">
        <description>
          <narrative>RSSH -&gt; RSSH: Integrated service delivery and quality improvement -&gt; Quality of care</narrative>
        </description>
      </budget-item>
      <budget-item code="1a0e253d-91c8-4657-9773-7b54dc8e3409" percentage="0.04">
        <description>
          <narrative>RSSH -&gt; RSSH: Integrated service delivery and quality improvement -&gt; Service organization and facility management</narrative>
        </description>
      </budget-item>
      <budget-item code="2c422db1-945a-4222-b6eb-8ea39fbf434f" percentage="1.56">
        <description>
          <narrative>RSSH -&gt; RSSH: Laboratory systems -&gt; Information systems and integrated specimen transport networks</narrative>
        </description>
      </budget-item>
      <budget-item code="951569a8-a591-40fc-9492-c7eb2322279f" percentage="0.14">
        <description>
          <narrative>RSSH -&gt; RSSH: Laboratory systems -&gt; National laboratory governance and management structures</narrative>
        </description>
      </budget-item>
      <budget-item code="30f85a5d-1110-4276-932f-a742fc65c90f" percentage="0.54">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="8194063f-1bf8-4be2-9ebd-2823d5ac44a3" percentage="1.53">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="a93b0a8f-4b2d-4b43-806e-06b2f2240144" percentage="4.64">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="9afa836c-5fc6-4ff5-973e-19cb5f9bc599" percentage="0.02">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Collaborative activities with other programs and sectors (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="e5d69248-af9e-44de-a99d-c2557c675f55" percentage="0.23">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="70cce1e1-1248-426c-b949-2fe2feec2c0a" percentage="0.02">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key Populations (TB care and prevention) - Children</narrative>
        </description>
      </budget-item>
      <budget-item code="87435fc1-d92b-4039-b203-96061e6e85be" percentage="0.01">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="2b47e4dd-6430-4bc5-829c-127bb93a72a8" percentage="4.35">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2146ce4f-9254-4a2a-8be8-e14734ab53dc" percentage="0">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="d5851297-913c-4ce3-a373-c0915334727a" percentage="0.04">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Prevention</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2021-01-01" />
      <period-end iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-01-01">3579825.40</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">7565850.55</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2023-01-01" />
      <period-end iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-01-01">2633505.67</value>
    </budget>
    <capital-spend percentage="9.53" />
    <transaction ref="b92934ad-db94-4e1a-8178-8bd9fd3fa686">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-01-14" />
      <value currency="USD" value-date="2021-01-14">6874040.09</value>
      <description>
        <narrative>Global Fund commitment to DJI-Z-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f0d6f613-b23b-4a7e-aeaa-8633054a0712">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-01-20" />
      <value currency="USD" value-date="2021-01-20">3807002.85</value>
      <description>
        <narrative>Global Fund disbursement to DJI-Z-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5967e017-b98e-400c-8211-def218a6a62a">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-03-30" />
      <value currency="USD" value-date="2021-03-30">25000.00</value>
      <description>
        <narrative>Global Fund commitment to DJI-Z-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a13bdc55-1710-4bb0-9ca3-17005843d436">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-04-01" />
      <value currency="USD" value-date="2021-04-01">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to DJI-Z-UNDPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="71bb50dd-3c1d-449b-b700-50b3359025ea">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-07-07" />
      <value currency="USD" value-date="2021-07-07">25000.00</value>
      <description>
        <narrative>Global Fund commitment to DJI-Z-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a4b0fd39-c5d8-4d6b-99cc-f5d0a7c8ba36">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-09-23" />
      <value currency="USD" value-date="2021-09-23">2619377.00</value>
      <description>
        <narrative>Global Fund disbursement to DJI-Z-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3551b7ec-862f-40b7-951a-415eab99b1f2">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-20" />
      <value currency="USD" value-date="2021-10-20">3112493.24</value>
      <description>
        <narrative>Global Fund commitment to DJI-Z-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4753d1df-0062-4a05-ba06-3dd027d07141">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-20" />
      <value currency="USD" value-date="2021-10-20">-447660.24</value>
      <description>
        <narrative>Global Fund commitment to DJI-Z-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="acaed4ba-6bde-419e-985c-f8eeb826ad53">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-21" />
      <value currency="USD" value-date="2021-10-21">2664833.00</value>
      <description>
        <narrative>Global Fund disbursement to DJI-Z-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="10c89c5b-d815-45b0-b514-afbaf23066ea">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-22" />
      <value currency="USD" value-date="2021-10-22">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to DJI-Z-UNDPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e34531f9-498f-428f-aed9-4e4c18884788">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-02-24" />
      <value currency="USD" value-date="2022-02-24">25000.00</value>
      <description>
        <narrative>Global Fund commitment to DJI-Z-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="449d9f37-8da9-4632-8c1f-d00375d8a82e">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-06-09" />
      <value currency="USD" value-date="2022-06-09">447659.89</value>
      <description>
        <narrative>Global Fund disbursement to DJI-Z-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ce417183-f321-477d-88ff-0010e10e838f">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-21" />
      <value currency="USD" value-date="2022-10-21">-0.35</value>
      <description>
        <narrative>Global Fund commitment to DJI-Z-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5b62e73c-f1a8-406b-a79b-449b9a57758d">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-21" />
      <value currency="USD" value-date="2022-10-21">1090577.67</value>
      <description>
        <narrative>Global Fund commitment to DJI-Z-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d02f9481-beac-40c1-b13a-41491c3aa6ae">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-10-27" />
      <value currency="USD" value-date="2022-10-27">600000.00</value>
      <description>
        <narrative>Global Fund disbursement to DJI-Z-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9fffc5bd-2db8-43f0-816b-bb88351a7b50">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-02" />
      <value currency="USD" value-date="2022-11-02">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to DJI-Z-UNDPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="291aa783-571b-4164-b225-21445818d28a">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-19" />
      <value currency="USD" value-date="2022-12-19">490577.67</value>
      <description>
        <narrative>Global Fund disbursement to DJI-Z-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9fac53d8-e4f3-4b83-af87-e6c358adbb07">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-02-01" />
      <value currency="USD" value-date="2023-02-01">1491085.31</value>
      <description>
        <narrative>Global Fund commitment to DJI-Z-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="410e2ee0-89e8-44ab-a652-371acb59924e">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-02-07" />
      <value currency="USD" value-date="2023-02-07">1056171.34</value>
      <description>
        <narrative>Global Fund disbursement to DJI-Z-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="01344d6b-ddeb-4cff-b313-37c7e49e8f18">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-06-14" />
      <value currency="USD" value-date="2023-06-14">1441856.00</value>
      <description>
        <narrative>Global Fund commitment to DJI-Z-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="11a9cfe8-0fe5-49cb-8a52-7bdd19f2dc8c">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-06-14" />
      <value currency="USD" value-date="2023-06-14">-434913.97</value>
      <description>
        <narrative>Global Fund commitment to DJI-Z-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c048b058-1f03-4bd0-b374-f5a55dddc996">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-20" />
      <value currency="USD" value-date="2023-06-20">1441856.00</value>
      <description>
        <narrative>Global Fund disbursement to DJI-Z-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="eaddda11-48c9-4467-9ec3-737da3d2f7fb">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-23" />
      <value currency="USD" value-date="2023-07-23">25000.00</value>
      <description>
        <narrative>Global Fund commitment to DJI-Z-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="98443fda-1ef6-4e5e-9b8e-9266c4bf6672">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-31" />
      <value currency="USD" value-date="2023-08-31">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to DJI-Z-UNDPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="56d722f3-d6c3-443d-b151-a6bba0f36f89">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-11-28" />
      <value currency="USD" value-date="2023-11-28">157350.00</value>
      <description>
        <narrative>Global Fund commitment to DJI-Z-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="582f8d2a-6316-41e1-91d8-d1b52420777d">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-12-01" />
      <value currency="USD" value-date="2023-12-01">157350.00</value>
      <description>
        <narrative>Global Fund disbursement to DJI-Z-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fe6d3331-2bbc-420e-ae0e-deb847afef77">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-30" />
      <value currency="USD" value-date="2024-09-30">-13230.08</value>
      <description>
        <narrative>Global Fund commitment to DJI-Z-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f82da815-e62e-4310-bc2f-8beb84013686">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-10-01" />
      <value currency="USD" value-date="2024-10-01">13230.08</value>
      <description>
        <narrative>Funds returned to the Global Fund from DJI-Z-UNDPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1559d4f1-4045-407d-9a33-08e399781232">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-06-13" />
      <value currency="USD" value-date="2025-06-13">263124.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from DJI-Z-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="121aecc4-25ac-488e-8511-31fd98e33ccd">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-17" />
      <value currency="USD" value-date="2025-06-17">-263124.00</value>
      <description>
        <narrative>Global Fund commitment to DJI-Z-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6c0e547b-ae08-4ac4-a031-da14ced32144">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-06-24" />
      <value currency="USD" value-date="2025-06-24">239250.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from DJI-Z-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="791f6799-e344-46fa-abe8-18ec5aa5ee99">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-27" />
      <value currency="USD" value-date="2025-06-27">-239250.00</value>
      <description>
        <narrative>Global Fund commitment to DJI-Z-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="28868eb1-e154-45c6-b03c-567a9022ae22">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-08-01" />
      <value currency="USD" value-date="2025-08-01">280.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from DJI-Z-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="881ec6b2-7687-46ac-8384-c3de9bee8dad">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-08-07" />
      <value currency="USD" value-date="2025-08-07">-280.00</value>
      <description>
        <narrative>Global Fund commitment to DJI-Z-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1f4ac42d-61e2-4f41-b80c-a2e51b62de29">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-05-05" />
      <value currency="USD" value-date="2026-05-05">4130.14</value>
      <description>
        <narrative>Funds returned to the Global Fund from DJI-Z-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8c2884fd-1a76-4821-ae65-276c9ba91c22">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-05-15" />
      <value currency="USD" value-date="2026-05-15">-4130.14</value>
      <description>
        <narrative>Global Fund commitment to DJI-Z-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="DJI-Z-UNDPP01-EXP-20211231">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-12-31">3579825.80</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for DJI-Z-UNDPP01, Jan 2021 to Dec 2021.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="DJI-Z-UNDPP01-EXP-20221231">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-12-31">5369494.84</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for DJI-Z-UNDPP01, Jan 2022 to Dec 2022.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="DJI-Z-UNDPP01-EXP-20231231">
      <transaction-type code="4" />
      <transaction-date iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-12-31">4328036.27</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for DJI-Z-UNDPP01, Jan 2023 to Dec 2023.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="DJI-Z-UNDPP01-EXP-20240630">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-06-30" />
      <value currency="USD" value-date="2024-06-30">51788.66</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for DJI-Z-UNDPP01, Jan 2024 to Jun 2024.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/DJI-Z-UNDP" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-07" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment at private sector sites</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment at private sector sites</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="100" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 6302; Denominator: 6302.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 471; Denominator: 471.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 6113; Denominator: 6113.</narrative>
            </comment>
          </target>
          <actual value="96.6">
            <comment>
              <narrative>Numerator: 1050; Denominator: 1087.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 5807; Denominator: 5807.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 280; Denominator: 280.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="96" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 45570; Denominator: 45570.</narrative>
            </comment>
          </target>
          <actual value="94.7">
            <comment>
              <narrative>Numerator: 55610; Denominator: 58705.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 44203; Denominator: 44203.</narrative>
            </comment>
          </target>
          <actual value="96">
            <comment>
              <narrative>Numerator: 37984; Denominator: 39561.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 41993; Denominator: 41993.</narrative>
            </comment>
          </target>
          <actual value="96.5">
            <comment>
              <narrative>Numerator: 37309; Denominator: 38664.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of suspected malaria cases that receive a parasitological test at private sector sites</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Proportion of suspected malaria cases that receive a parasitological test at private sector sites</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="100" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 15432; Denominator: 15432.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 3673; Denominator: 3673.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 14969; Denominator: 14969.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 7898; Denominator: 7898.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 14661; Denominator: 14661.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 7534; Denominator: 7534.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="100" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 209855; Denominator: 209855.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 216098; Denominator: 216098.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 203559; Denominator: 203559.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 205782; Denominator: 205782.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 193381; Denominator: 193381.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 201601; Denominator: 201601.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive results among the total HIV tests performed during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" ascending="0" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive results among the total HIV tests performed during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="1.49">
          <comment>
            <narrative>Numerator: 394; Denominator: 26535.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="0.96">
            <comment>
              <narrative>Numerator: 400; Denominator: 41515.</narrative>
            </comment>
          </target>
          <actual value="1.2">
            <comment>
              <narrative>Numerator: 309; Denominator: 24929.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="0.91">
            <comment>
              <narrative>Numerator: 450; Denominator: 49462.</narrative>
            </comment>
          </target>
          <actual value="1.1">
            <comment>
              <narrative>Numerator: 280; Denominator: 25574.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="0.87">
            <comment>
              <narrative>Numerator: 500; Denominator: 57464.</narrative>
            </comment>
          </target>
          <actual value="1">
            <comment>
              <narrative>Numerator: 253; Denominator: 25982.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="44" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="60" />
          <actual value="31" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="60" />
          <actual value="58" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="60" />
          <actual value="60" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="44" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="60" />
          <actual value="26" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="60" />
          <actual value="56" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="60" />
          <actual value="53" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative>
      </title>
      <description>
        <narrative>Module: PMTCT.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="33.88">
          <comment>
            <narrative>Numerator: 41; Denominator: 121.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="45.45">
            <comment>
              <narrative>Numerator: 50; Denominator: 110.</narrative>
            </comment>
          </target>
          <actual value="39.1">
            <comment>
              <narrative>Numerator: 43; Denominator: 110.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="56.07">
            <comment>
              <narrative>Numerator: 60; Denominator: 107.</narrative>
            </comment>
          </target>
          <actual value="18.7">
            <comment>
              <narrative>Numerator: 20; Denominator: 107.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="68.63">
            <comment>
              <narrative>Numerator: 70; Denominator: 102.</narrative>
            </comment>
          </target>
          <actual value="33.7">
            <comment>
              <narrative>Numerator: 28; Denominator: 83.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="64.03">
          <comment>
            <narrative>Numerator: 559; Denominator: 873.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="64.03">
            <comment>
              <narrative>Numerator: 559; Denominator: 873.</narrative>
            </comment>
          </target>
          <actual value="38">
            <comment>
              <narrative>Numerator: 332; Denominator: 873.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="74.46">
            <comment>
              <narrative>Numerator: 650; Denominator: 873.</narrative>
            </comment>
          </target>
          <actual value="84.5">
            <comment>
              <narrative>Numerator: 738; Denominator: 873.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="80.18">
            <comment>
              <narrative>Numerator: 700; Denominator: 873.</narrative>
            </comment>
          </target>
          <actual value="81.2">
            <comment>
              <narrative>Numerator: 709; Denominator: 873.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="64.6">
          <comment>
            <narrative>Numerator: 1544; Denominator: 2390.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="64.6">
            <comment>
              <narrative>Numerator: 1544; Denominator: 2390.</narrative>
            </comment>
          </target>
          <actual value="29.4">
            <comment>
              <narrative>Numerator: 702; Denominator: 2390.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="71.05">
            <comment>
              <narrative>Numerator: 1698; Denominator: 2390.</narrative>
            </comment>
          </target>
          <actual value="67.7">
            <comment>
              <narrative>Numerator: 1619; Denominator: 2390.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="74.6">
            <comment>
              <narrative>Numerator: 1783; Denominator: 2390.</narrative>
            </comment>
          </target>
          <actual value="92.3">
            <comment>
              <narrative>Numerator: 2206; Denominator: 2390.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="1825" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="1900" />
          <actual value="1799" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="1800" />
          <actual value="2151" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="1800" />
          <actual value="2218" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="84.19" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="85" />
          <actual value="84.7">
            <comment>
              <narrative>Numerator: 1440; Denominator: 1701.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="86" />
          <actual value="81.8">
            <comment>
              <narrative>Numerator: 1472; Denominator: 1799.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="87" />
          <actual value="84.7">
            <comment>
              <narrative>Numerator: 1822; Denominator: 2151.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="75.51" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="82.54" />
          <actual value="70.7">
            <comment>
              <narrative>Numerator: 41; Denominator: 58.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="89.47" />
          <actual value="76.3">
            <comment>
              <narrative>Numerator: 58; Denominator: 76.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90.2" />
          <actual value="65.6">
            <comment>
              <narrative>Numerator: 42; Denominator: 64.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of PLHIV on ART who initiated TB preventive therapy among those eligible during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of PLHIV on ART who initiated TB preventive therapy among those eligible during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="47.12" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="55" />
          <actual value="33.8">
            <comment>
              <narrative>Numerator: 71; Denominator: 210.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="60" />
          <actual value="57.7">
            <comment>
              <narrative>Numerator: 109; Denominator: 189.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="65" />
          <actual value="57.5">
            <comment>
              <narrative>Numerator: 122; Denominator: 212.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="83.56" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="87">
            <comment>
              <narrative>Numerator: 1653; Denominator: 1900.</narrative>
            </comment>
          </target>
          <actual value="80.5">
            <comment>
              <narrative>Numerator: 1448; Denominator: 1799.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 1620; Denominator: 1800.</narrative>
            </comment>
          </target>
          <actual value="77.1">
            <comment>
              <narrative>Numerator: 1658; Denominator: 2151.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 1710; Denominator: 1800.</narrative>
            </comment>
          </target>
          <actual value="79.4">
            <comment>
              <narrative>Numerator: 1762; Denominator: 2218.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="27.65">
          <comment>
            <narrative>Numerator: 1880; Denominator: 6799.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="38.27">
            <comment>
              <narrative>Numerator: 2485; Denominator: 6493.</narrative>
            </comment>
          </target>
          <actual value="35">
            <comment>
              <narrative>Numerator: 2273; Denominator: 6493.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="44.55">
            <comment>
              <narrative>Numerator: 2851; Denominator: 6399.</narrative>
            </comment>
          </target>
          <actual value="33">
            <comment>
              <narrative>Numerator: 2109; Denominator: 6399.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="51.78">
            <comment>
              <narrative>Numerator: 3273; Denominator: 6321.</narrative>
            </comment>
          </target>
          <actual value="31.3">
            <comment>
              <narrative>Numerator: 2295; Denominator: 7335.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of long-lasting insecticidal nets distributed to at-risk populations through mass campaigns</narrative>
      </title>
      <description>
        <narrative>Module: Vector control.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of long-lasting insecticidal nets distributed to at-risk populations through mass campaigns</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="151832" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="30000" />
          <actual value="19984" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="212851" />
          <actual value="247839" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="30000" />
          <actual value="30000" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of population protected by IRS within the last 12 months in areas targeted for IRS</narrative>
      </title>
      <description>
        <narrative>Module: Vector control.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Proportion of population protected by IRS within the last 12 months in areas targeted for IRS</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="97" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="71" />
          <actual value="116.8">
            <comment>
              <narrative>Numerator: 98228; Denominator: 84135.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="80" />
          <actual value="101.8">
            <comment>
              <narrative>Numerator: 67077; Denominator: 65898.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90" />
          <actual value="93.1">
            <comment>
              <narrative>Numerator: 63664; Denominator: 68376.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>